USFDA designates Zydus’ Usnoflast an orphan drug for ALS treatment EP News Bureau Jan 23, 2025 Usnoflast (ZYIL1) is a novel, oral small-molecule NLRP3 inhibitor. It has been studied in several pre-clinical models of…
